GSK set up centers to boost biopharma research
GlaxoSmithKline Pharmaceuticals has launched Trust in Science Program to develop doctoral programs (PhDs) in the fields of biostatistics and bioinformatics.
Under this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs. GSK Pharmaceutical Ltd. will provide funding and ensure all course content is shaped to address current industry needs and opportunities. Students with a master’s degree in biostatistics, maths, and bioinformatics are eligible for the PhD courses.
GSK’s “Trust in Science” initiative is a public-private partnership model to build R&D capacity for development and discovery in science. The pillars of this initiative are: scientific excellence, trust and talent development in line with GSK’s Science, Technology and Culture values. The initiative was launched in 2011 initially to engage with leading researchers and institutions in Latin America, focused on Brazil and Argentina.
During the launch, Dr. Renu Swarup, Secretary, Department of Biotechnology said, “We would like to create more opportunities in India for post graduate doctoral education in science. The GSK – RCB collaboration allows us to do just that, specifically in two niche, high-valued fields: biostatistics and bioinformatics. The goal is to provide students with a specialized course that addresses current industry needs and opportunities. This, we believe, will help them better contribute to India’s biopharma and medical research needs.”